4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-15-022570
CIK 0001411158operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:17 PM ET
Size
5.0 KB
Accession
0001209191-15-022570
Insider Transaction Report
Form 4
Maples Kirk R
Senior VP Program Mgt
Transactions
- Sale
Common Stock
2015-03-02$43.95/sh−600$26,369→ 9,020 total
Footnotes (2)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.64 to $44.52, inclusive.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:17 PM ET
- Size
- 5.0 KB